Molecular basis of Kell blood group phenotypes

Vox Sanguinis

Volumn 73, Issue 1, 1997, Pages 1-11

  Lee, Soohee ^a  

^a NEW YORK BLOOD CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID SUBSTITUTION; AMINO TERMINAL SEQUENCE; ANTIGEN EXPRESSION; BLOOD GROUP KELL SYSTEM; GENE MUTATION; GENE SEQUENCE; NEWBORN HEMOLYTIC DISEASE; NUCLEIC ACID BASE SUBSTITUTION; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS;

EID: 0030820550     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1423-0410.1997.7310001.x     Document Type: Review

References (72)

1. Coombs R, Mourant A, race R: Detection of weak and incomplete Rh agglutmins: new test, Lancet 1945;2:15-16.
2. Marsh WL, Redman CM: Recent developments in the Kell blood group system. Transfus Med Rev 1987;1:4-20.
3. Redman CM, Marsh WL: The Kell blood group system and the McLeod Phenotypes. Serum Haematol 1993;30:209-218
4. Redman CM, Lee S: The Kell Blood group system, Transfus Clin Biol 1995;4:243-249.
5. Redman CM, Lee S, Kell blood group system and the McLeod syndrome: in Cartron J-P, Rouger P (eds): Blood Cell Biochemistry. Molecular Basis of Major Blood Group Antigens. New York, Plenum Press. 1995,pp 227-242.
6. ISBI Working Party on Terminology for Red Cell Surface Antigens: Blood group terminology 1995. Vox Sang 1995;69:265-279.
7. ISBT ICSH Working Party: Terminology for red cell surface antigens. Vox Sang 1996;71:246-248.
8. Redman CM, Marsh WL, Scarborough A, Johnson CL, Rabin BI, Overbeek M: Biochemical studies on McLeod Phenotype red cells and isolation of Kx antigen. Br J. Haematol 1988;68:131-136.
9. Khamlichi S, Bailly P, Blanchard D, Goosens D, Carton JP, Bertrand O: Purification and Partial characterization of the erythrocyte Kx Protein deficient in McLeod patients. Eur J Biochem 1995;228:931-934.
10. Russo DC, Redman C: Association of Kell with neighbouring proteins in the red cell membrane, Mol Biol Cell 1995;6:51a.
11. Branch DR, Sy Siok Hian AL, Petz LD: Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells. Br J Haematol 1985;59:505-512.
12. Daniels G: Kell and Kx blood group systems; in Human Blood Groups. Oxford, Blackwell Science, 1995, pp 385-420.
13. Anstee DJ: Blood group-active surface molecules of the human red blood cell. Vox Sang 1990;58:1-20
14. Lee S, Zambas ED, Marsh WL, Redman CM: Molecular cloning and primary structure of Kell blood group protein. Proc Natl Acad Sci USA 1991;88:6353-6357.
15. Ho M, Chelly J, Carter N, Danek A, Crocker P, Monaco AP: Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994;77:869-880.
16. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M: ECE-1: A membrane-bound metalloprotease that catalyses the proteolyti activation of big endothelin-1. Cell 1994;78:473-485.
17. Shipp MA, Vijayaraghvan J, Schmidt FV, Masteller EL, D'Adamio L, Hersh L.B, Reinherz EL: Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 Cenkephalinase: Direct evidence by cDNA transfection analysis. Proc Natl Acad Sci USA 1989;86:297-301.
18. HYP Consortium: A gene (PEN) with homologies to endopeptides is mutated in patients with X-linked hypophosphatemic rickets. Nature Genet 1995;11:130-136.
19. Turner AJ. Murphy LJ, Medeiros MS, Barnes K: Endopeptidse-24.11 (neprilysin) and relatives Twenty years on. Adv Exp Med Biol 1996;389:141-148.
20. Malfroy B, Burnier J: New substrates for enkephalinase (neutral endopeptidase) based on fluorescence energy transfer, Biochem Biophys Res Commun 1987;143:58-66.
21. Devault A, Lazure C, Nault C, LcMoual R, Scidah NG, Chretien M, Kahn P, Powell J, Mallet J, Beaumont A, et al: Ammo acid sequence of rabbit kidney neutral endopeptidase 24.11 (enkephalinase) deduced from a complementary DNA. EMBO J 1987;6:1317-1322.
22. Letarte M, Vera S, Tran R, Addis JB, Onizuka RJ, Quackenbusch EJ, Jongeneel CV, McInnes RR: Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase J Exp Med 1988;168:1247-1253.
23. Zelinski T, Coghlan G, Myal Y, Shiu RP, Philipps S, White L, Lewis M: Genetic linkage between the Kell blood group system and prolactin-inducible protein locr Provisional assignment of KEL to chromosome 7. Ann Hum Genet 1991;55:137-140.
24. Murphy MT, Morrison N, Miles JS, Fraser RH, Spurr NK, Boyd F: Regional chromosomal assignment of the Kell blood group locus (KEL) to chromosome 7q33-q35 by fluorescence in situ hybridization: Evidence for the polypeptide nature of antigenic variation Hum Genet 1993;91:585-588.
25. Lee S, Zambas ED, Marsh WL, Redman CM: The human Kell blood group gene maps to chromosome 7q33 and its expression is restricted to erythroid cells. Blood 1993,81:2804-2809.
26. Lee S, Zambas L, Green LD, Redman C: Organization of the gene encoding the human Kell blood group protein Blood 1985;85:1364-1370.
27. Lee S, Wu X, Reid M. Zehnski T, Redman C: Molecular basis of the Kell (KI) phenotype. Blood 1985;85:912-916.
28. Lee S, Wu X, Reid M, Redman C: Molecular basis of the K6-7 [Js(a-b-) phenotype in the Kell blood group system. Transfusion 1995;35:822-825.
29. Lee S, Wu X, Son S, Naime D, Reid M, Okubo Y, Sistonen P, Redman C: Point mutations characterize KEL. 10. the KEL3. KEL.4 and KEL2/ alleles. and the KEL17 and KEL11 alleles. Transfusion 1996;36:490-494.
30. Giblett ER: Is 'new' blood group antigen found in negroes. Nature 1958;181:1221-1221.
31. Redman CM, Lee S, ten Huinink D, Rabin BL, Johnson CL, Oyen R, Marsh WL: Comparison of human and chimpanzee Kell blood group systems. Transfusion 1989;29:486-490.
32. MacArthur MW, Thornton JM: Influence of proline residues on protein conformation. J Mol Biol 1991;218:397-412.
33. Yun RH, Anderson A, Hermans J: Proline in alpha-helix: Stability and conformation studied by dynamics simulation Proteins 1991;10:219-228.
34. Branch DR, Muenseh HA, Sy Siok Hian AL, Petz LD: Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity Br J Haematol 1983;54:573-578.
35. Furuhjelm U, Nevanlinna HR, Nurkka R, Gavin J, Lippett P, Gooch A, Sanger R: The blood group antigen Ula (Karhula). Vox Sang 1968;15:118-124.
36. Marsh WL, Redman CM, Kessler LA, DiNapoli J, Searborough AL, Philipps AG, Mody KM: K23. A low-incidence antigen in the Kell blood group system identified by biochemical characterization. Transfusion 1987;27:36-40.
37. Jones J, Reid ME, Oyen R, Harris T, Moscarelli S, Co S, Leger R, Beal C, Cardillo K: A novel common Kell antigen. TOU. and its spatial relationship to other Kell antigens. Vox Sang 1995;69:53-60.
38. Winkler MM, Beatttie KM, Cisco SL, Sigmund KE, Johnson CL, Rabin BI, Marsh WL: The Kmod blood group phenotype in a healthy individual. Transfusion 1989;29:642-645.
39. Kline WE, Sullivan CM, Bowman RJ: A rare example of weakened expression of the Kell (KI) antigen Vox Sang 1984;47:170-173.
40. Garratty G: Target antigens for red-cell-bound autoantibodies, in Nance S.I (ed): Clinical and Basic Science Aspects of immunohematology Arlington. American Association of Blood Banks. 1991, pp 33-72.
41. Vengelen-Tyer V, Gonzalez B, Grraty G, Kruppe C, Johnson CL, Mueller KA, Marsh WL: Acquired loss of red cell Kell antigens. Br J. Haematol 1987;65:231-234.
42. Williamson LM, Poole J, Redman C, Clark N, Liew YW, Russo DC, Lee S, Reid MF, Black AJ: Transient loss of proteins carrying Kell and Luthran red cell antigens during consecutive relapses of autoimmune trombocytopenia. Br. J Haematol 1994;87:805-812.
43. Daniels GL, Weinauer F, Stone C, Ho M, Green CA, Jahn-Jochem H, Offner R, Monaco AP: A combination of the effects of rare genotypes at the VK and KEL blood group loci results in absence of Kell system antigens from the red blood cell. Blood 1996;88:4045-4050.
44. Russo DC, Lee S, Reid M, Redman CM: Topology of Kell blood group protein and the expression of multiple antigens by transfected cells, B Blood 1994;84:3518-3523.
45. Petty AC, Monoclonal antibody-specific immobilisation of erythrocyte antigens (MAIEA). A new technique to selectively determine antigenic sites on red cell membranes. J Immunol Methods 1993;161:91-95.
46. Reid ME, Oyen R, Redman CM, Gillespie G, Jones J, Eckrich R: K 12 is located on the Kell blood group protein in proximity to K k and Js' Js', Vox Sang 1995;68:40-45.
47. Daniels GL, Petty AC, Reid M, Moulds M, Devenish A, Halil O: Demonstration by the monoclonal antibody-specific immobilization of erythrocyte antigens assay that a new red cell antigen belongs to the Kell blood group system Transfusion 1994;34:818-820.
48. Petty AC, Daniels GL, Tippett P: Application of the MAIEA assay to the Kell blood group system. Vox Sang 1994;66:216-224.
49. Jongerus JM, Daniels GL, Overbeeke MAM, Petty AC, Reid M, Oyen R, Rijksen H, Van Leeuwen EF: A new low-incidence antigen in the Kell blood group system VLAN (KEL 25), Vox Sang 1996;71:43-47.
50. Caine ME, Mueller-Heubach E: Kell sensitization in pregnancy. Am J Obset Gynecol 1986;154:85-90.
51. Mayne KM, Bowell PJ, Pratt GA: The significance of anti-Kell sensitization in pregnancy. Clin Lab Haematol 1990;12:379-385.
52. Leggal HM, Gibson JM, Barron SL, Reid MM: Anti-Kell in pregnancy, Br J Obstel Gynaceol 1991;98:162-165.
53. Inglis G, Fraser RH, McTaggart S, Sheridan R, Forrest AH, Mitchell R: Monoclonal antibodies to high-incidence Kell epitopes: Characterization and application in automated screening of donor samples. Transfus Med 1994;4:209-212.
54. Berkowitz RL, Beyth Y, Sadovsky E: Death in utero due to Kell sensitization without excessive elevation of the delta OD450 value in amniotic fluid. Obset Gynecol 1982;60:746-749.
55. Bowman JM, Pollock JM, Manning FA, Harman CR, Menticoglou S: Maternal Kell blood group alloimmunization. Obstet Gynecol 1992;79:239-244.
56. Hessner MJ, McFarland JG, Endean DJ: Genotyping of KELL and KEL 2 of the human Kell blood group system by the polymerase chain reaction with sequence-specific primers. Transfusion 1996;36:495-499.
57. Farr V, Gray E: Pregnancy outcome in mothers who develop Kell antibodies. Scott Med J 1988;33:300-303.
58. Contreras M Antenatal tests in the diagnosis, and assessment of severity of haemolytic disease (IId) of the fetus and newborn (hdn) Vox Sang 1994;67: Suppl 3:207-210.
59. Garner SE, Gorick BD, Lan WY, Brown D, Taverner J, Hughes-Jones NC, Contreras M, Lubenko A: Prediction of the severity of haemolytic disease of the new born. Quantitative IgG anti-D subclass determinations explain the correlation with functional assay results Vox Sang 1995;68:169-176.
60. Vaughan JI Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM: Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994.171:247-252.
61. Wemer CP, Widness JA, Decreased fetal eyrth- ropotesis and hemolysis in Kell hemoltytic anemia. Am J Obstet Gynecol 1996;174:547-551.
62. Parilla BV, Socol ML: Hydrops fetalis with Kell isoimmunization. Obstet Gynecol 1996;88:730.
63. Avent ND, Martin PG: Kell typing by allele-specific PCR (ASP) Br J Haematol 1996;93:728-730.
64. Lee S, Bennett PR, Overton I, Warwick R, Wu X, Redman CM: Prenatal diagnosis of Kell blood group genotypes: KEL1 and KEL2. Am J Obstet Gynecol 1996;175:455-459.
65. Moncharmont P, Juron-Dupraz F, Doillon M, Vignal M, Debeaux P: A case of hemolytic disease of the newborn infant due to anti-K (Cellano). Acta Haematol 1991;85:45-46.
66. Duguid JK, Bromilow JM: Haemolytic disease of the newborn due to anti-k. Vox Sang 1990;58:69.
67. Bowman JM, Harman FA, Manning CR, Pollock JM: Frythroblastosis fetalius produced by anti-k. Vox Sang 1989;56:187-189.
68. +). Indian J Pathol Microbiol 1994;37:431-434.
69. + -negative recipients at risk for having children with clinically significant hemolytic disease of the newborn. Vox Sang 1994;66:46-48.
70. Gordon MC, Kennedy MS, O'Shaughnessy RW, Waheed A: Severe hemolytic disease of the newborn due to anti-Js'. Vox Sang 1995;69:140-141.
71. Sakuma K, Suzuki H, Ohto H, Tsuneyama H, Uchikawa M First ease of hemolytic disease of the newborn due to anti-Ul antibodies. Vox Sang 1994;66:293-294.
72. Fourmaintraux A, Vitrac D, Mariette JB, Brunel F: The Ko phenotype and fetal-maternal alloimmunization Arch FR Pediatr 1993;50:779-781.